Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Doximity, Inc. stock logo
DOCS
Doximity
$24.32
+1.3%
$26.63
$19.71
$36.29
$4.54B1.181.71 million shs741,054 shs
PetMed Express, Inc. stock logo
PETS
PetMed Express
$3.98
+0.5%
$4.61
$3.92
$16.18
$84.18M0.73380,353 shs274,178 shs
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Doximity, Inc. stock logo
DOCS
Doximity
+1.33%+3.12%-5.72%-11.56%-30.03%
PetMed Express, Inc. stock logo
PETS
PetMed Express
+0.51%-1.73%-16.39%-34.75%-72.93%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Doximity, Inc. stock logo
DOCS
Doximity
3.2404 of 5 stars
3.00.00.00.02.44.21.9
PetMed Express, Inc. stock logo
PETS
PetMed Express
3.1523 of 5 stars
3.02.00.00.03.71.72.5

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Doximity, Inc. stock logo
DOCS
Doximity
2.07
Hold$28.8218.50% Upside
PetMed Express, Inc. stock logo
PETS
PetMed Express
2.00
Hold$13.25232.91% Upside

Current Analyst Ratings

Latest WOSG, TUI, DOCS, and PETS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/25/2024
Doximity, Inc. stock logo
DOCS
Doximity
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeUnderweight ➝ Neutral$25.00
4/23/2024
Doximity, Inc. stock logo
DOCS
Doximity
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingUnderweight ➝ Underweight$25.00 ➝ $25.00
4/2/2024
Doximity, Inc. stock logo
DOCS
Doximity
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingIn-Line ➝ In-Line$30.00
3/15/2024
Doximity, Inc. stock logo
DOCS
Doximity
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetUnderweight ➝ Underweight$22.00 ➝ $25.00
2/26/2024
Doximity, Inc. stock logo
DOCS
Doximity
Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Perform
2/26/2024
Doximity, Inc. stock logo
DOCS
Doximity
SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageMarket Perform$32.00
2/9/2024
Doximity, Inc. stock logo
DOCS
Doximity
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$28.00 ➝ $29.00
2/9/2024
Doximity, Inc. stock logo
DOCS
Doximity
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$25.00 ➝ $27.00
(Data available from 5/3/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Doximity, Inc. stock logo
DOCS
Doximity
$419.05M10.83$0.72 per share33.81$4.98 per share4.88
PetMed Express, Inc. stock logo
PETS
PetMed Express
$256.86M0.33$0.53 per share7.50$5.22 per share0.76

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Doximity, Inc. stock logo
DOCS
Doximity
$112.82M$0.6636.8531.583.0629.39%16.08%13.76%5/16/2024 (Confirmed)
PetMed Express, Inc. stock logo
PETS
PetMed Express
$5.14M-$0.39N/A39.80N/A-2.92%-1.25%-0.75%5/27/2024 (Estimated)

Latest WOSG, TUI, DOCS, and PETS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/16/2024N/A
Doximity, Inc. stock logo
DOCS
Doximity
$0.2040N/A-$0.2040N/AN/AN/A  
4/15/2024Q3 2024
PetMed Express, Inc. stock logo
PETS
PetMed Express
N/A-$0.10-$0.10-$0.10N/A$65.32 million
2/8/2024Q3 2024
Doximity, Inc. stock logo
DOCS
Doximity
$0.19$0.25+$0.06$0.26$127.46 million$135.28 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Doximity, Inc. stock logo
DOCS
Doximity
N/AN/AN/AN/AN/A
PetMed Express, Inc. stock logo
PETS
PetMed Express
N/AN/A-6.75%N/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Doximity, Inc. stock logo
DOCS
Doximity
N/A
8.03
8.03
PetMed Express, Inc. stock logo
PETS
PetMed Express
N/A
1.32
0.84

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Doximity, Inc. stock logo
DOCS
Doximity
87.19%
PetMed Express, Inc. stock logo
PETS
PetMed Express
73.33%

Insider Ownership

CompanyInsider Ownership
Doximity, Inc. stock logo
DOCS
Doximity
39.40%
PetMed Express, Inc. stock logo
PETS
PetMed Express
3.60%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Doximity, Inc. stock logo
DOCS
Doximity
977186.55 million113.05 millionNot Optionable
PetMed Express, Inc. stock logo
PETS
PetMed Express
30221.15 million20.39 millionOptionable

WOSG, TUI, DOCS, and PETS Headlines

SourceHeadline
How to keep your pet healthy, and your wallet safe, while going to the vetHow to keep your pet healthy, and your wallet safe, while going to the vet
madison.com - May 2 at 7:15 PM
Contrarian Options Traders Have a Tempting Opportunity with PetMed Express (PETS)Contrarian Options Traders Have a Tempting Opportunity with PetMed Express (PETS)
msn.com - April 30 at 4:33 PM
Trade of the Day: Bet on a Short Squeeze in PetMed Express (PETS) StockTrade of the Day: Bet on a Short Squeeze in PetMed Express (PETS) Stock
investorplace.com - April 30 at 8:34 AM
PetMed Express Names Sandra Campos President, CEOPetMed Express Names Sandra Campos President, CEO
marketwatch.com - April 29 at 6:28 PM
Tech Moves: Matt Hulett steps down as PetMed Express CEO; Seattle startup Avante adds execsTech Moves: Matt Hulett steps down as PetMed Express CEO; Seattle startup Avante adds execs
msn.com - April 29 at 1:27 PM
PetMed Express, Inc. Names Sandra Campos as new Chief Executive Officer and PresidentPetMed Express, Inc. Names Sandra Campos as new Chief Executive Officer and President
globenewswire.com - April 29 at 8:15 AM
Mirae Asset Global Investments Co. Ltd. Decreases Stock Holdings in PetMed Express, Inc. (NASDAQ:PETS)Mirae Asset Global Investments Co. Ltd. Decreases Stock Holdings in PetMed Express, Inc. (NASDAQ:PETS)
marketbeat.com - April 28 at 4:26 AM
Struggling to find care for your pet in need? Here are some tips.Struggling to find care for your pet in need? Here are some tips.
newschannel5.com - April 22 at 12:00 PM
Pet Supermarket Highlights CBD to Address Pets Stress and AnxietyPet Supermarket Highlights CBD to Address Pets' Stress and Anxiety
finance.yahoo.com - April 18 at 9:53 AM
Is pet insurance worth the bark? Survey reveals middling resultsIs pet insurance worth the bark? Survey reveals middling results
wral.com - April 16 at 3:00 PM
Consumer Reports | Why pet owners aren’t satisfied with their pet insuranceConsumer Reports | Why pet owners aren’t satisfied with their pet insurance
wsls.com - April 15 at 10:44 PM
Have pets? Here are alternatives to pet insurance for saving moneyHave pets? Here are alternatives to pet insurance for saving money
ksat.com - April 15 at 5:43 PM
PetMed Express Non-GAAP EPS of -$0.10, revenue of $65.3M beats by $0.3MPetMed Express Non-GAAP EPS of -$0.10, revenue of $65.3M beats by $0.3M
msn.com - April 15 at 5:43 PM
PETS Stock Earnings: PetMed Express Misses EPS, Beats Revenue for Q3 2024PETS Stock Earnings: PetMed Express Misses EPS, Beats Revenue for Q3 2024
investorplace.com - April 15 at 2:03 PM
PetMed Express, Inc.: PetMeds Announces Fiscal 2024 Third Quarter Financial Results and Completion of Financial RestatementPetMed Express, Inc.: PetMeds Announces Fiscal 2024 Third Quarter Financial Results and Completion of Financial Restatement
finanznachrichten.de - April 15 at 12:43 PM
PetMeds® Announces Fiscal 2024 Third Quarter Financial Results and Completion of Financial RestatementPetMeds® Announces Fiscal 2024 Third Quarter Financial Results and Completion of Financial Restatement
markets.businessinsider.com - April 15 at 12:43 PM
PetMeds® Announces Fiscal 2024 Third Quarter Financial Results and Completion of Financial RestatementPetMeds® Announces Fiscal 2024 Third Quarter Financial Results and Completion of Financial Restatement
globenewswire.com - April 15 at 8:16 AM
P.E.T.S sends 5,000th pup to new home along Underdog ExpressP.E.T.S sends 5,000th pup to new home along Underdog Express
texomashomepage.com - April 11 at 11:16 PM
Should you pay for pet insurance?Should you pay for pet insurance?
msn.com - April 11 at 6:16 PM
Is pet insurance worth it?Is pet insurance worth it?
msn.com - April 8 at 10:35 PM
Pet Owners be Aware: These Popular Spring Flowers are Toxic to PetsPet Owners be Aware: These Popular Spring Flowers are Toxic to Pets
wkdq.com - April 8 at 5:34 PM
March PET flake market reportMarch PET flake market report
ccfgroup.com - April 6 at 10:25 PM
Survey shows ‘paw-rents unhappy with pet insurance. Here are some other ways to saveSurvey shows ‘paw'-rents unhappy with pet insurance. Here are some other ways to save
msn.com - April 6 at 12:24 PM
Bottom Line: Alternatives to purchasing pet insuranceBottom Line: Alternatives to purchasing pet insurance
actionnews5.com - April 4 at 2:08 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Doximity logo

Doximity

NASDAQ:DOCS
Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.
PetMed Express logo

PetMed Express

NASDAQ:PETS
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards, as well as television advertising under the 1-800-PetMeds, PetCare Rx, and PetMeds brands. The company was incorporated in 1996 and is headquartered in Delray Beach, Florida.